NCT04272034 2025-10-16Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid TumorsIncyte CorporationPhase 1 Terminated105 enrolled
NCT04234113 2025-01-08Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsSotio Biotech Inc.Phase 1 Terminated115 enrolled
NCT04672980 2022-12-08RTX-321 Monotherapy in Patients With HPV 16+ TumorsRubius TherapeuticsPhase 1 Terminated9 enrolled
NCT04596033 2022-07-15TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell TherapyGenocea Biosciences, Inc.Phase 1 Terminated49 enrolled
NCT03677960 2019-07-24Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) InfectionAntiva BiosciencesPhase 1 Terminated6 enrolled
NCT02407561 2018-01-25Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression AssaysCastle Biosciences IncorporatedTerminated3 enrolled